Exposure Response Analysis of Safety of Elotuzumab in Patients with Multiple Myeloma

被引:0
|
作者
Passey, Chaitali [1 ]
Gibiansky, Leonid [2 ]
Sheng, Jennifer [1 ]
Bello, Akintunde [1 ]
Roy, Amit [1 ]
Gupta, Manish [1 ]
机构
[1] Bristol Myers Squibb, Clin Pharmacol & Pharmacometr, Princeton, NJ USA
[2] QuantPharm LLC, North Potomac, MD USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
T-81
引用
收藏
页码:S85 / S85
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of elotuzumab for the treatment of multiple myeloma
    Gavriatopoulou, Maria
    Terpos, Evangelos
    Kastritis, Efstathios
    Dimopoulos, Meletios A.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (02) : 237 - 245
  • [2] Effects of elotuzumab on QT interval and cardiac safety in patients with multiple myeloma
    Passey, Chaitali
    Darbenzio, Raymond
    Jou, Ying-Ming
    Lynch, Mark
    Gupta, Manish
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (06) : 1237 - 1244
  • [3] Effects of elotuzumab on QT interval and cardiac safety in patients with multiple myeloma
    Chaitali Passey
    Raymond Darbenzio
    Ying-Ming Jou
    Mark Lynch
    Manish Gupta
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 1237 - 1244
  • [4] Elotuzumab in multiple myeloma
    Burki, Talha Khan
    LANCET ONCOLOGY, 2018, 19 (12): : E675 - E675
  • [5] Safety and efficacy of Elotuzumab combination therapy for patients with multiple myeloma: A systematic review and meta-analysis
    Noori, Maryam
    Fayyaz, Farimah
    Rezaei, Nima
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (03) : 327 - 338
  • [6] Elotuzumab in multiple myeloma
    Bruzzese, Antonella
    Martino, Enrica Antonia
    Vigna, Ernesto
    Iaccino, Enrico
    Mendicino, Francesco
    Lucia, Eugenio
    Olivito, Virginia
    Filippelli, Gianfranco
    Neri, Antonino
    Morabito, Fortunato
    Gentile, Massimo
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (01) : 7 - 10
  • [7] Elotuzumab for the treatment of multiple myeloma
    Wang, Yucai
    Sanchez, Larysa
    Siegel, David S.
    Wang, Michael L.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [8] Elotuzumab for the treatment of multiple myeloma
    Moreau, Philippe
    Touzeau, Cyrille
    FUTURE ONCOLOGY, 2014, 10 (06) : 949 - 956
  • [9] Elotuzumab for the treatment of multiple myeloma
    Yucai Wang
    Larysa Sanchez
    David S. Siegel
    Michael L. Wang
    Journal of Hematology & Oncology, 9
  • [10] Population pharmacokinetic and exposure–response analyses of elotuzumab plus pomalidomide and dexamethasone for relapsed and refractory multiple myeloma
    Takafumi Ide
    Mayu Osawa
    Kinjal Sanghavi
    Heather E. Vezina
    Cancer Chemotherapy and Pharmacology, 2022, 89 : 129 - 140